RPL13 and spondyloepimetaphyseal dysplasia: Therefore, it is possible that the disease mechanism of SEMD-RPL13 is not caused by a complete loss-of-function or haploinsufficiency, since carrier status of heterozygous deletions has not been reported in humans and could potentially be incompatible with life.